3540 — CI Medical Co Cashflow Statement
0.000.00%
Last trade - 00:00
- ¥39bn
- ¥55bn
- ¥46bn
- 43
- 40
- 41
- 33
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 2,149 | 4,451 | 4,285 | 3,851 | 3,184 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -29.8 | 313 | 271 | 13 | -26 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1,005 | -876 | -3,322 | -2,849 | -4,319 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 1,402 | 4,160 | 1,579 | 1,411 | -139 |
Capital Expenditures | -260 | -459 | -2,831 | -9,348 | -8,930 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 5.09 | -305 | -220 | -701 | -865 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -255 | -764 | -3,051 | -10,049 | -9,795 |
Financing Cash Flow Items | — | — | — | -8 | -23 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -133 | -151 | -584 | 6,710 | 9,825 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1,012 | 3,231 | -2,030 | -1,918 | -33 |